HER2 iPSC-CAR-M

N/A

Report date: 2024/04/01 13:46:03

Base Information

Drug NameHER2 iPSC-CAR-M
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionAnti-HER2
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHuaxiayuan Cell Engineering Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuaxiayuan Cell Engineering Group Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A